Injectable Nanocomposite Implants Reduce ROS Accumulation and Improve Heart Function after Infarction

Area of Science:

• Biomedical Engineering
• Cardiovascular Research
• Nanotechnology

Background:

• Myocardial infarction (MI) causes ischemia, leading to reactive oxygen species (ROS) generation, cell death, and scar tissue formation.
• Current therapies for MI often struggle to fully restore cardiac function and prevent adverse remodeling.
• There is a need for innovative treatments that can mitigate ischemia-reperfusion injury and promote cardiac repair.

Purpose of the Study:

• To develop and evaluate an injectable extracellular matrix-gold nanoparticle composite hydrogel for treating myocardial infarction.
• To assess the efficacy of the hydrogel in absorbing reactive oxygen species (ROS) and protecting cardiac tissue.
• To investigate the impact of the hydrogel therapy on cardiac function, scar size, and inflammatory response in vivo.

Main Methods:

• Fabrication of an injectable composite hydrogel incorporating gold nanoparticles within an extracellular matrix.
• In vitro assessment of the hydrogel's capacity to absorb ROS.
• In vivo evaluation in a mouse ischemia-reperfusion model, assessing cardiac morphology, vascular integrity, scar size, inflammation, and heart function.

Main Results:

• The composite hydrogel effectively absorbed ROS in vitro and in vivo.
• Gold nanoparticles within the hydrogel facilitated rapid electrical signal transfer between cardiac cells, promoting functional assembly.
• Treatment with the hydrogel preserved cardiac tissue morphology, maintained blood vessel integrity, reduced scar size, and decreased inflammation.
• Significant prevention of heart function deterioration was observed in treated mice.

Conclusions:

• The injectable extracellular matrix-gold nanoparticle composite hydrogel represents a promising new therapy for myocardial infarction.
• This novel hydrogel mitigates ischemia-reperfusion injury by absorbing ROS and enhancing electrical coupling in cardiac tissue.
• The therapy demonstrates significant potential for preserving cardiac function and reducing adverse remodeling after heart attack.